Lebrikizumab Side Effects
Medically reviewed by Drugs.com. Last updated on Apr 10, 2025.
Applies to lebrikizumab: parenteral prefilled pen or syringe.
Side effects include:
Most common (≥1%) adverse reactions were conjunctivitis, injection site reactions, herpes zoster.
For healthcare professionals
Applies to lebrikizumab: subcutaneous solution.
Dermatologic adverse events
- Uncommon (up to 1%): Herpes zoster[Ref]
Hematologic
- Uncommon (0.1% to 1%): Eosinophilia[Ref]
Local
- Common (1% to 10%): Injection site reaction[Ref]
Ocular
See also:
References
1. (2024) "Product Information. Ebglyss Pre-filled Pen (lebrikizumab)." Eli Lilly Canada Inc
More about lebrikizumab
- Check interactions
- Compare alternatives
- Reviews (2)
- Dosage information
- During pregnancy
- Drug class: interleukin inhibitors
- Breastfeeding
- En español
Patient resources
Other brands
Professional resources
Other brands
Related treatment guides
Further information
Lebrikizumab side effects can vary depending on the individual. Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
Note: Medication side effects may be underreported. If you are experiencing side effects that are not listed, submit a report to the FDA by following this guide.
